The liver contains two types of galactose receptors, specific for Kupffer and parenchymal cells respectively. These receptors are only expressed in the liver, and therefore are attractive targets for the specific delivery of drugs. We provided low-density lipoprotein (LDL), a particle with a diameter of 23 nm in which a variety of drugs can be incorporated, with terminal galactose residues by lactosylation. Radioiodinated LDL, lactosylated to various extents (60-400 mol of lactose/ mol of LDL), was injected into rats. The plasma clearance and hepatic uptake of radioactivity were correlated with the extent of lactosylation. Highly lactosylated LDL (> 300 lactose/LDL) is completely cleared from the blood by liver within 10 min. Pre-injection with N-acetylgalactosamine blocks liver uptake, which indicates that the hepatic recognition sites are galactose-specific. The hepatic uptake occurs mainly by parenchymal and Kupffer cells. At a low degree of lactosylation, approx. 60 lactose/LDL, the specific uptake (ng/mg of cell protein) is 28 times higher in Kupffer cells than in parenchymal cells. However, because of their much larger mass, parenchymal cells are the main site of uptake. At high degrees of lactosylation (> 300 lactose/LDL), the specific uptake in Kupffer cells is 70-95 times that in parenchymal cells. Under these conditions, Kupffer cells are, despite their much smaller mass, the main site of uptake. Thus not only the size but also the surface density of galactose on lactosylated LDL is important for the balance of uptake between Kupffer and parenchymal cells. This knowledge should allow us to design particulate galactose-bearing carriers for the rapid transport of various drugs to either parenchymal cells or Kupffer cells.
INTRODUCTION
In the liver, both Kupffer and parenchymal cells have receptors on their plasma membranes that specifically bind and internalize ligands with terminal D-galactose residues. The receptor on parenchymal cells is the classical asialoglycoprotein receptor originally described by Ashwell & Morell [1] . The receptor on Kupffer cells, which was described more recently [2] , is different from the receptor on parenchymal cells [3] . Recent evidence suggests that the receptor on Kupffer cells might be identical with serum amyloid P, a circulating lectin [4] .
The two receptor systems have similar carbohydrate-binding specificities, but it has been suggested that there is a difference in their capacity to internalize ligands of various sizes [5] . Unlike parenchymal cells, Kupffer cells are unable to internalize small galactose-terminated molecules such as asialofetuin (diameter 4.5 nm) via their galactose-specific receptors [6, 7] . Gold particles coated with asialofetuin are, however, taken up readily by Kupffer cells [2, 7] .
Since the galactose-specific receptors are only expressed on Kupffer and liver parenchymal cells and not at other sites in the body, they are attractive targets for the specific delivery of drugs and other material to these liver cells. To be able to direct drugs specifically with an adequate carrier to either receptor, it is essential to have more detailed information about the specificities of the two receptor systems for potential carriers. In the present study, we have investigated the role of the density of galactose residues on a particle in uptake via the two receptor systems. We have used for our studies low-density lipoprotein (LDL) because it forms a homogeneous population of particles with a diameter of 23 nm, to which various amounts of D- galactose residues can be coupled by reductive lactosamination. LDL is an attractive transport vehicle, as it is an endogenous particulate carrier that is not rapidly removed from the circulation by the reticuloendothelial system. Furthermore, it has been demonstrated that it can accommodate up to 100 drug molecules in its oily core [8] .
EXPERIMENTAL

Reagents
Collagenase type I, N-acetyl-D-galactosamine, N-acetyl-D-glucosamine, BSA (fraction V), agarose-bound neuraminidase (from Clostridium perfringens; type VI-A) and fetuin (type IV) were obtained from Sigma, St. Louis, MO, U.S.A. 125I (carrier free) and [D-glucose-l-4C]lactose were supplied by Amersham International, Amersham, Bucks., U.K. Lactose was supplied by Merck, Darmstadt, Germany. Sodium cyanoborohydride was from Aldrich, Brussels, Belgium. Gadolinium chloride (GdCI3) was obtained from Janssen, Beerse, Belgium. All other chemicals were analytical grade.
Fetuin was desialylated enzymically by incubating the protein, dissolved in 0.1 M-sodium acetate buffer, pH 5.5, with agarosebound neuraminidase (20 m-units/ml) for 4 h at 37 'C. A minimum of 80 % of the sialic acid residues, assayed as described previously [9] , was removed by this procedure.
Isolation, radiolabelling and lactosylation of LDL Human LDL (1.019 < d < 1.063) was isolated by two repetitive centrifugations as described previously [10] . The lipoprotein was labelled with 125I as described previously [11] . [12] At the indicated times, liver lobules were tied off and excised, and at the end of the experiment the remainder of the liver was removed. The amount of liver tissue tied off successively did not exceed 15 % of the total liver mass. Radioactivity in liver at each time point was calculated from-the radioactivities and weights of the liver samples, and corrected for the radioactivity in plasma present in the tissue at the time of sampling (85 ,ul/g fresh wt. [13] ).
Isolation of liver cells
Rats were anaesthesized and injected with 1251I-LDL or lactosylated 125I-LDL as described in the previous section. At 10 min after injection, the vena porta was canulated and the liver was perfused with Ca2+-free Hanks balanced salt solution containing 10 mM-Hepes, pH 7.4 (8°C), at a flow rate of 14 ml/min. After 8 min, a lobule was tied off for determination of the total liver uptake. Then the liver was perfused with 0.05 % (w/v) collagenase in Hanks medium containing 10 mM-Hepes, pH 7.4, and parenchymal and non-parenchymal cells were isolated as described previously [11] . The non-parenchymal cell preparation was further fractionated into endothelial and Kupffer cells by centrifugal elutriation as described in detail previously [14] . The contributions of the various cell types to the total liver uptake were calculated as described previously [14] . As found previously with other substrates [11, 14, 15] , no significant amounts of radioactivity were lost from the cells during the isolation procedure. This was checked in each experiment by comparing the calculated liver uptake (i.e. the summation of the contributions of the various cell types) with the value actually measured in the liver lobule.
Determination of proteins
Protein concentrations in homogenates, cell suspensions and solutions of LDL were determined by the method of Lowry et al. [16] , with BSA as standard. The values found for LDL were multiplied by a factor 0.82 to correct for the higher colour yield of apolipoprotein B [17] . Plasma clearance and liver association of lactosylated LDL Native LDL disappears very slowly from the circulation of the rat (half-life of 5-10 h), and only 2.1 + 0.1 % (mean+ S.E.M. of 8 animals) of the injected dose is found in liver at 10 min after injection of radiolabelled LDL. To study the effect of the coupling of lactose to LDL on its plasma clearance and liver uptake, rats were injected with preparations of 125I-LDL that had been lactosylated for 8, 24, 72 or 168 h. Fig. 2 shows that all preparations of lactosylated LDL are cleared from the plasma at significantly higher rates than for native LDL. The rapidity of clearance is correlated with the length of the lactosylation period. At high degrees of lactosylation, obtained after > 72 h of incubation, virtually all of the injected material is cleared from the circulation within O min. The decrease in plasma radioactivity coincides with an increase in the radioactivity associated with liver. The radioactivity in liver is maximal at 10 min after injection, and subsequently declines. The decrease in liver radioactivity is accompanied by a rise in the trichloroacetic acidsoluble radioactivity in plasma. In rats injected with 168 hlactosylated 1251I-LDL, for instance, the acid-soluble radioactivity in plasma increases from 0.1 +0.1 0% of the dose at 1 min after injection to 4.1 + 0.1 % at 40 min after injection (means+ S.E.M.; 3 rats). These results suggest that lactosylated LDL, once associated with the liver, is degraded to acid-soluble products that rapidly diffuse to the blood. Subcellular-fractionation studies, performed as described by De Duve et al. [19] , indicate that lysosomes are involved in the intracellular processing of lactosylated LDL in the liver (results not shown).
RESULTS
Coupling
The mechanism of the liver association of lactosylated LDL was determined in several ways. Fig. 3 shows that pre-injection with N-acetylgalactosamine (400 mg/kg body wt.) almost completely inhibits the plasma clearance and liver association of all the lactosylated LDL preparations, whereas preinjection with the same dose of N-acetylglucosamine has no effect at all. In further experiments, rats were injected with 125I-LDL that had been incubated for 168 h with either sodium cyanoborohydride alone (50 mg/ml) or with sodium cyanoborohydride (50 mg/ml) in combination with cellobiose (100 mg/ml). At O min after injection, the livers of these animals contained only 3.8 + 1.1 % and 6.4 + 1.3 % of the injected dose respectively (means+ S.E.M.; 3 rats). These results indicate that the introduced terminal galactose residues of lactosylated LDL are responsible for the hepatic uptake of the particle, and that uptake is not due to other modifications (e.g. oxidation of lipids and/or the apoprotein).
Uptake of lactosylated LDL by liver cells
To study the effect of lactosylation of LDL on the recognition of the lipoprotein by the various cell types in the liver, rats were injected with '25I-LDL that had been lactosylated for 0-168 h; 10 min later, the liver was perfused, and Kupffer, endothelial and parenchymal cells were isolated. The cell isolation procedure was performed at a low temperature (4-8°C) to prevent degradation of the internalized material. Fig. 4 shows that the uptake by all the three liver cell types increases with the incubation time, i.e. with increasing degree of lactosylation. After 8 h of incubation, when approx. 60 molecules of lactose are bound per LDL particle, the association of radioactivity to the liver cells is 6-8 times higher than the association of native 1251-LDL. At this relatively low degree of lactosylation, the galactose-mediated association of lactosylated LDL to Kupffer cells (expressed as ng/mg of cell protein) is 28 and 4 times higher than to parenchymal and endothelial cells respectively (Fig. 5) . Parenchymal cells are, nevertheless, the main site of hepatic uptake, since these cells contribute > 90 % to the liver protein mass, and Kupffer and endothelial cells only a small percentage. Incubation for longer than 8 h results in the association of larger amounts of lactosylated LDL with the liver cells. However, the increase in uptake by Kupffer cells is relatively larger than that by parenchymal cells. Fig. 5 shows that, after injection of 1251I. LDL that has been lactosylated for 72 h or longer (> 300 lactose/LDL), the galactose-mediated association of radioactivity to Kupffer cells is 70-95 times the association to parenchymal cells. At these high ratios Kupffer cells, despite their small number and size, are responsible for the major part (approx. 60 %) of the liver uptake.
Modulation of the intrahepatic distribution of lactosylated LDL by GdCI3 and asialofetuin
The results of the previous section indicate that Kupffer cells are the main site of uptake of 168 h-lactosylated 1251I-LDL. Recently it was found that in rats receptor-mediated endocytosis by Kupffer cells is selectively inhibited by pretreating the animals with GdCl3 [20] . Surprisingly, pretreatment of rats with GdCl3 had no effect on the liver uptake of 168 h-lactosylated 1251I-LDL. It appears that the intrahepatic distribution of the internalized material is, however, dramatically altered (Fig. 6a) . The uptake by Kupffer cells is virtually abolished. The capacity of the liver Vol. 270
to remove 168 h-lactoslyated LDL from the circulation is, however, not seriously affected, since the impaired uptake by Kupffer cells in GdCl3-pretreated animals is compensated by a much higher uptake by parenchymal cells. These cells then account for 95 % of the total liver uptake.
Galactose-mediated uptake by parenchymal liver cells can be blocked specifically with asialofetuin. This galactose-terminated glycoprotein inhibits internalization via the galactose-specific receptors on parenchymal liver cells, but not galactose-mediated uptake by Kupffer cells [6] . Pre-injection of rats with asialofetuin (50 mg/kg body wt.) has no large effect on the liver uptake of 168 h-lactosylated 1251I-LDL (Fig. 6b) . However, the pre-injection considerably changes the contributions of the various liver cell types to the total hepatic uptake. Internalization by parenchymal cells is much decreased. The inability of asialofetuin to decrease the total liver uptake is explained by the finding that the lower internalization by parenchymal cells is compensated by a higher uptake by Kupffer cells.
The effect of asialofetuin on the liver uptake of 8 h-lactosylated 125I-LDL is different. Pre-injection with asialofetuin (50 mg/kg) decreases the hepatic uptake at 10 min after injection from 27.2 + 11.3 % of the dose to 4.5 + 1.8 % (means + S.E.M.; 3 rats).
DISCUSSION
In the present study we show that incubation of LDL with lactose and sodium cyanoborohydride results in a reproducible time-dependent covalent coupling oflactose to the apolipoprotein. Maximally, about 400 molecules of lactose can be bound per LDL particle. After intravenous injection into rats, lactosylated LDL is rapidly cleared from the circulation, owing to galactosespecific uptake by the liver. In an earlier study by Attie et al. [21] , it was found that LDL containing 200-250 lactose residues per particle is cleared from plasma at a much lower rate (half-life approx. 45 min) than shown here. We do not have an explanation for the discrepancy between those earlier results and the present data. However, the short plasma half-lives of lactosylated LDL observed in our study comply with the rapid plasma clearance seen after lactosylation of other proteins, e.g. serum albumin, ferritin and RNA A [22] [23] [24] [25] .
Lactosylated LDL is taken up via hepatic galactose-specific receptors. Uptake of the particles via (extra)hepatic LDL receptors is probably low, since the lysine residues of the apoprotein, which are involved in the interaction with the LDL receptor [26, 27] , are modified by the lactosylation procedure. Furthermore, the galactose-receptor-mediated plasma clearance of lactosylated LDL is much faster than the LDL-receptor-mediated clearance of native heterologous or homologous LDL (plasma half-life several hours) [28] .
In the liver, lactosylated LDL is mainly taken up Kupffer cells do not internalize small galactose-terminated molecules such as asialofetuin [6] . Galactose-specific uptake by these cells can be induced by coating several molecules of asialofetuin on to gold particles [2, 7] . This In an earlier study it was concluded that only particles with a size of maximally 10 nm are internalized via the galactose receptors on parenchymal cells [7] . We have found, however, that lactosylated LDL, a particle of diameter 23 nm, can be taken up rapidly via these receptors. The earlier studies were performed with gold particles that were coated with asialofetuin. In the analysis of their data the authors [7] did not, however, take into account the size of the asialofetuin molecules (diameter approx. 4.5 nm) that were coated on to the particles. The sizes of the particles were therefore underestimated, which may explain, at least in part, the difference between the earlier work and the present data. The ability of parenchymal cells to internalize relatively large particles via their galactose-receptors is advantageous, as it implies that relatively large quantities of drugs may be introduced into parenchymal cells via this route.
What are the factors that determine the contributions of Kupffer and parenchymal cells to the hepatic uptake of galactosecontaining particles? It has been suggested previously that the size of the particles determines the intrahepatic distribution [2, 7] . In the present study we demonstrate that the number of galactose residues on a particle is also important. Furthermore, it appears that the mode of coupling of galactose residues to LDL is, for unknown reasons, important. We have shown previously that, if a galactose-terminated cholesterol derivative is incorporated into the lipid moiety of LDL, less than 10 % of the liver uptake occurs by parenchymal cells [11] . We 
